The invention relates to a coating agent for spray coating an object with at least one alkylsilane used for creating a hydrophobic and/or oleophobic coating and additives used for facilitating application. The alkylsilane is provided at a concentration of less than 10 percent while the additives comprise a solvent and/or a diluted solvent which is selected at a low viscosity such that the coating agent can be sprayed in droplets having an average diameter of less than 100 µm, preferably less than 50 µm.

The present invention is directed to the preparation of optionally pigmented spreading paste based on multiphase mixtures of ionically-modified polyurethanes and/or polyurethane ureas which are prepared from special synthesis components based on silicone resins, aromatic hydroxypolyethers, aromatichydroxy polyesters, and perfluorocarbon resins, the multiphase mixtures additionally containing water and organic solvents for the polyurethanes and/or polyurethane ureas. The present invention is also directed to the preparation of these optionally pigmented spreading pastes and to their use for the production of coatings permeable to water vapor on fabric or leather substrates by the direct or transfer method using the technique of evaporation.

A composition based on water and/or organic solvents and their use as a finish on flat materials, comprising,

A composition based on water and/or organic solvents and their use as a finish on flat materials, comprising,

The present invention concerns new colouring agents comprising a chromophore bound to one or more molecules of a mono- or di-saccharide, the process to prepare them, and their use in the dyeing of textile fibres.

There is disclosed a composition for forming a protective coating upon a substrate. The composition has been found particularly useful for forming a protective coating upon components of automotive vehicles, such as a bedliner for a pick-up truck. The composition may include, without limitation, an isocyanate component and an amine component and optionally includes one or more of a catalyst, stabilizer, pigment, fire retardant or other additives.

The present invention relates to a process for the preparation of a composition comprising unsaturated compounds, in particular polyunsaturated compounds, which comprises concentrating and purifying the compounds by contact with silicon and/or aluminum derivatives. The process of the invention represents an advantageous substitute of the usual distillation processes, coupled or not to chromatographic processes, and allows to isolate and remove polar byproducts.

A multi-chamber bottle comprises in one chamber a bleaching composition and in another chamber a bleach sensitive formulation. The viscosity of the bleaching composition is controlled by an admixture of a thickener and a hydrocarbon. The density of the bleaching composition is controlled by the presence of an ionic salt.

Cosmetic or dermatological formulations which comprise one or more active ingredients selected from phylloquinone, 2-hydroxy-5-methyllaurophenone oxime, vitamin A and its derivatives, vitamin E and its derivatives, vitamin H, allantoin, bisabolol, nicotinic acid derivatives and caffeine and in addition (a) one or more antioxidants and/or (b) one or more UV filters, are distinguished, in particular, by the fact that the active ingredients present in the formulation according to the invention are stabilised.

A composition comprising a basic drug, a drug which forms a zwitterion, or a salt of either entity, admixed with a polymer selected from hydroxypropylmethylcellulose acetate succinate (HPMCAS), cellulose acetate trimellitate (CAT), cellulose acetate phthalate (CAP), hydroxypropylcellulose acetate phthalate (HPCAP), hydroxypropylmethyl-cellulose acetate phthalate (HPMCAP), and methylcellulose acetate phthalate (MCAP). The compositions having improved solubility, hence bioavailability, in the small intestine; Processes for testing such compositions, and methods of using such compositions. The compositions comprise the basic drug, zwitterion, or salt and one or more of the aforementioned polymers. The invention further relates to a method for increasing the bioavailability of a basic or a zwitterionic drug comprising co-administering the basic drug, the zwitterionic drug, or the salt, with one or more of the aforementioned polymers.